Open AccessOZ101, an oligofructose prebiotic, may prolong sulphonylurea efficcy in patients with type 2 diabetes: a pilot study: OZ101 and sulphonylurea-mediated glycaemic control
Author(s) -
Nick N. Gorgani
Publication year - 2022
Publication title -
research review
Language(s) - English
Resource type - Journals
ISSN - 2693-5007
DOI - 10.52845/cmro/2022/5-6-2
Subject(s) - medicine , type 2 diabetes , diabetes mellitus , regimen , endocrinology , area under the curve , gastroenterology